diallyl trisulfide has been researched along with Autoimmune Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; Li, S; Li, Z; Liu, Y; Tang, X; Wang, H; Xu, Y; Xue, X; Yang, Y; Yu, L; Zhang, J; Zhang, Y | 1 |
1 other study(ies) available for diallyl trisulfide and Autoimmune Diabetes
| Article | Year |
|---|---|
Diallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activation.
Topics: Allyl Compounds; Animals; Antioxidants; Apoptosis; Caspase 3; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Expression Regulation; Heme Oxygenase-1; Humans; Myocardial Infarction; NF-E2-Related Factor 2; Oxidative Stress; Rats; Reperfusion Injury; Sirtuin 1; Sulfides | 2017 |